Popular Biotech News, Healthcare News and Pharma News

17:34 EDT 20th October 2016 | BioPortfolio

Dozens of cases Enterovirus D68 (EV-D68) reported in UK – Stoke Sentinel

Stoke SentinelDozens of cases Enterovirus D68 (EV-D68) reported in UKStoke SentinelParents are being advised about a virus which can leave children paralysed – as dozens of cases have been reported so far in the UK this year. Enterovirus D68 (EV-D68) has so far infected 38 children in the UK this year and parents are advised to watch ...Warning after rise in incurable bug that can leave children...

Variety, not intensity, key to exercising an elderly heart

Frequent, low-intensity exercise provides the best cardiac and overall health outcomes for an aging population. 



Otrivine Mu-Cron discontinued

Novartis has discontinued Otrivine Mu-Cron (paracetamol, pseudoephedrine hydrochloride) with immediate effect.

LION-HEART: IV Drug May Lower Hospitalization in CHF Patients

Intermittent administration of IV levosimendan lowered natriuretic-peptide levels, which translated into clinical improvements in patients with advanced, chronic HF, suggests new study from Spain. Heartwire from Medscape

GMO Answers Highlights Academics Review Critique of Steven Druker’s Book Altered Genes, Twisted Truth

“Altered Genes, Twisted Truth: How the Venture to Genetically Engineer Our Food Has Subverted Science, Corrupted Government, and Systematically Deceived the Public” by Steven Druker. In Academics Review, GMO Answers Independent Expert Dr. Bruce Chassy recently reviewed Steven Druker’s book titled Altered Genes, Twisted Truth. Dr. Chassy notably points out the multiple fallacies within the bo...

Fostair® (beclometasone and formoterol) 200/6 high strength formulation now available for asthma maintenance therapy at no additional cost

Manchester, 1 December 2015 – Chiesi Limited today announced that the high strength formulation of Fostair (beclometasone/formoterol) 200/6 is now available for the regular treatment of adult asthma where the use of an inhaled corticosteroid (ICS) and long-acting beta-2-agonist (LABA) combination product is appropriate and where treatment needs to be stepped up. The introduction of the new...

FDA approves Gilead’s Odefsy for treatment of HIV-1 infection

Gilead Sciences has announced that the US Food and Drug Administration (FDA) has approved its TAF-based single tablet regimen Odefsey (emtricitabine, rilpivirine and tenofovir alafenamide) for the treatment of HIV-1 infection in certain patients. read more

Ildong, Cellivery To Co-Develop Novel Biologic For Parkinson's

South Korean pharma firm Ildong and bioventure Cellivery have tied up to jointly develop an early stage, first-in-class therapy for Parkinson's disease using Cellivery's platform technology. The two hope the partnership will fundamentally change the therapeutic approach to the neurodegenerative disease.

Zhongmei Healthcare Plans $150 Million IPO in Hong Kong

Zhongmei Healthcare, a group of private China hospitals, plans to stage a $150 million IPO in Hong Kong during Q2. In January, the Carlyle Group acquired a 15.7% stake in Zhongmei for a $64 million investment, implying a valuation of $408 million. Zhongmei, which will offer 25% of its shares in the IPO, owns three renal care hospitals, one aesthetic surgical hospital and two general hospitals. The...

Allegheny Health Network Names Chief Medical Information Officer

Allegheny Health Network in Pittsburgh has appointed Dr. Robert White, as its new Chief Medical Information Officer. Dr. White joins Allegheny from the Cleveland Clinic where he has served as Associate Chief Medical Information Officer since 2011. Pittsburgh, PA (PRWEB) April 15, 2016 Allegheny Health Network (AHN) announced today that Robert White, MD, has been named Chief Medical Information Of...

GMC impose conditions on Dr Nigel Speight’s licence to practice | 23 April 2016

The ME Association’s paediatric medical adviser Dr Nigel Speight had conditions attached to his licence to practice by a panel of the General Medical Council on Wednesday (April 20). The...

Nutraceutical therapies for atherosclerosis

Nutraceuticals are natural compounds that are beneficial for the prevention or treatment of disease. In their Review, Moss and Ramji summarize the preclinical and clinical studies to evaluate the efficacy of various nutraceuticals, such as polyunsaturated fatty acids, flavanols, and vitamins C and E, for the prevention of atherosclerosis.

High-sensitivity LCMS requires high-purity nitrogen carrier gas

To help instrument manufacturer Shimadzu select the right source of nitrogen for its liquid chromatography-mass spectrometry (LC-MS) analysis, BOC conducted a study to analyse nitrogen interference from cylinder, liquid bulk vessel and generator nitrogen sources. This was the first study of the effects of nitrogen source purity on advanced LC-MS equipment. LC-MS requires nitrogen for drying, auxi...

Xbrane Biopharma AB: Xbrane submits GMP approval application for the production facility for Spherotide according to time plan

Press Release2016-08-01 Xbrane submits GMP approval application for the production facility for Spherotide according to time plan Xbranes subsidiary Primm Pharma has, according to the time plan, submitted the application to AIFA, the Italian Medicines Agency, for GMP approval of its production facility for Spherotide situated outside Naples, Italy. AIFA will during the coming 6 m...

Vistin Pharma ASA : Solid second quarter driven by all-time high metformin revenue

Oslo, Norway, 30 August 2016   Norwegian pharmaceutical company Vistin Pharma ASA (OSE: VISTIN) recorded its highest ever revenue from its main metformin business in the second quarter of 2016. The Company expects the metformin growth story to continue and is scaling up to meet future demand by expanding the production facility by 3,000 metric tonnes ("MT").   "We a...

Dr. Marc Gittelman of Optimal Health Miami Offers an Innovative Way to Help Patients Lose Weight - N.E.H. (Nutrition, Exercise and Hormones)

Aventura, FL, August 30, 2016 --( Obesity is a health epidemic in the United States, receiving much attention from news media as well as by medical professionals across the country. Dr. Marc Gittelman, director of Optimal Health Miami in Aventura, Florida, has seen many patients struggle to lose weight and to keep that weight off. Due to his personal experience with his patients, he unde...

Plan Bee: Combating the Declining Bee Population

SOURCE: Sanofi DESCRIPTION:A troubling trend has been preoccupying scientists: Honey bees are disappearing or dying at increasing rates. Last year alone, 44% of the bee colonies in the United States disappeared. While no exact cause has been determined, scientists have termed the issue Colony Collapse Disorder (CCD), a phenomenon in which very low or no adult honey bees are present in formerly act...

Alcon launches the NGENUITY® 3D Visualization System designed to further enhance retinal surgeon experience

Novartis International AG / Alcon launches the NGENUITY® 3D Visualization System designed to further enhance retinal surgeon experience . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Heads-up design using high definition 3D screen engineered to improve surgeons posture and may reduce fa...

BlueWind Medical’s Vivendi neurostimulator wins CE-mark approval to treat peripheral neuropathic pain

BlueWind Medical has received CE mark approval for its Vivendi miniature wireless neurostimulator for the treatment of peripheral neuropathic pain (PNP).

The hospital is a microcosm of America’s melting pot

“Doctor, why can’t my mother breathe?” he asked, eyes full of concern as he watched his mother’s chest heave like someone who has spent too long underwater. I turned up her oxygen as we discussed the possibilities we were testing for: infection, a reaction to chemotherapy, blood clots. Her breathing eased as we spoke, and […]

Precision Medicine Breakthrough for Chronic Myeloid Leukaemia

Scientists at the University of Glasgow have made a second significant breakthrough in the treatment of chronic myeloid leukaemia – using precision medicine to kill more than 90% of chronic myeloid leukaemia (CML) stem cells. CML is a rare form of blood cancer. An individual gets CML when normal blood stem cells are turned into leukaemic stem cells, or CML stem cells. These CML stem cells th...

Eisai’s Kisplyx approved in EU for kidney cancer

The European Commission has stamped its approval on the use of Eisai's Kisplyx to treat advanced kidney cancer.

Humana’s Bold Goal population health program seeks to topple barriers to healthy living

Humana’s population health initiative aims to slow the progression of chronic diseases by focusing on prevention and addresses food insecurity, transportation resources, and health literacy through community partnerships.

Intel Updates Q3 Revenue Outlook

SANTA CLARA (dpa-AFX) - Intel Corp. (INTC) announced the company now expects third-quarter revenue to be $15.6 billion, plus or minus $300 million, as compared to the previous range of $14.9 billi...

Ipsen Announces Data Presentation for Dysport® (abobotulinumtoxinA) at American Academy of Cerebral Palsy and Developmental Medicine

BASKING RIDGE, N.J., Sept. 21, 2016 /PRNewswire/ -- Ipsen Biopharmaceuticals, Inc., an affiliate of Ipsen (Euronext: IPN; ADR:  IPSEY), today announced that an additional data analysis regarding the safety and efficacy of repeated treatment sessions of Dysport® (abobotulinumtoxinA) in children (aged 2 and older) with lower limb spasticity will be presented at the annual me...

FDA issues clinical hold on CEL-SCI’s head and neck cancer study with Multikine

CEL-SCI Corp says it has received verbal notice from the US Food and Drug Administration that its Multikine…

FDA Announces Nivolumab Dose Change for RCC, NSCLC, Metastatic Melanoma

The FDA announced a modification to the recommended dosage regimen for nivolumab (Opdivo) for renal cell carcinoma (RCC), metastatic melanoma, and non–small-cell lung cancer (NSCLC).

Huanzhong Biotech to Market Concepta's Fertility Product in China

Shijiazhuang Huanzhong Biotech (HZ Biotech) will assemble and market a new women's fertility product in China developed by Concepta of the UK. The My Lotus product consists of test strips and electronic meters that measure a woman's cyclic urinic hormone levels, identifying the most likely time for conception. HZ Biotech will purchase the product from Concepta, market it, and provide post-market s...

US FDA Approves First 'Artificial Pancreas' In Medtronic's MiniMed 670G

The hybrid closed-loop automated insulin delivery system, the first closed-loop system approved anywhere in the world, automatically monitors glucose and...      Related StoriesAbbott Gains US Approval For Pro Version Of Flash Glucose SystemMore EU Audits, Post-Market Requirements: Tweeted Takeaways From ABHI MeetingKO’d By Allergy Failure, Circassia Looks To R...

Investing Wisely in Health Care Capital

This Viewpoint emphasizes the contribution of capital spending to escalating health care costs, and argues for improved understanding of the ways capital spending planning and investment can deliver important gains in health care value and population health.

Cellular Dynamics Spinoff Aims to Develop Vision-Restoring Therapies

Cellular Dynamics International is following a split with a spinoff. The Madison, WI-based biotech, which earlier this month announced it divided the company into two business units, is now saying it has launched a new venture that will focus on developing medicines to treat diseases of the retina. The new company, known as Opsis Therapeutics, […]

GENFIT: New Scientific Data to be Presented During Next AASLD Annual Meeting; Strong Involvement in the First-Ever NASH-TAG Conference

GENFIT:  New Scientific Data to be Presented During Next AASLD Annual Meeting; Strong Involvement in the First-Ever NASH-TAG Conference New data on experimental and clinical NASH biomarkers for the identification of NASH patients to be treated have been selected by the AASLD for presentations during its next Annual Meeting GENFIT to be a sponsor of the inaugural NASH-TAG educational co...

NICE rejects Keytruda in lung cancer, points to price and data

NICE has ruled that MSD's Keytruda shouldn't be used for non-small cell lung cancer on the NHS, saying the company's price is too high and its data incomplete. The first draft guidance is a major blow for patients with lung cancer hoping to receive new immunotherapy treatments, as NICE also recently issued a draft rejection of Keytruda's rival, BMS's Opdivo. The ruling is in contrast to adv...

Biogeochemistry: Rebalancing the global methane budget

A database of the carbon-isotope 'fingerprints' of methane has been used to constrain the contributions of different sources to the global methane budget. The surprising results have implications for climate prediction. See Letter p.88

Ageing: Measuring our narrow strip of life

In line with previous research, a demographic analysis corroborates the presence of a limit to human lifespan, indicating that increases in life expectancy are likely to slow down or stop over the coming years.

Dr. Oz: We Have a Loneliness Epidemic

Talk show host Dr. Mehmet Oz says there is a loneliness epidemic happening in America right now.

ARRÊT du TABAC: 28 jours sans fumer, c'est 5 fois plus de chance d'arrêter - BEH/INVS

Franchir une étape après l'autre et en groupe c'est un peu les fondements de cette campagne nationale anti-tabac qui « marche » au Royaume-Uni. Basée sur la preuve scientifique, qu'elle exploite astucieusement, l'initiative « Stoptober » a contribué fortement au fil des années à relever un véritable d&eacu...

Got Zika? For Pregnant Women, Lab Constraints Mean It’s Often Hard To Know

Testing people — especially pregnant women — who may have been exposed to the virus is an integral part of the response strategy, but it’s putting a strain on this part of the nation’s public health infrastructure. New congressional funding could change that.

Medigene-Aktie: Hohe zweistellige Kurse erwartet! Gutes Investment für risikobereite Anleger! Aktienanalyse

Kulmbach - Medigene-Aktie: Hohe zweistellige Kurse erwartet! Gutes Investment für risikobereite Anleger! Aktienanalyse Alfred Maydorn, Herausgeber des Maydorn Report, hält die Aktie des Biotechnolo...

Novavax Reschedules 4th Annual Investor and Analyst Meeting

GAITHERSBURG, Md., Oct. 07, 2016 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq:NVAX) today announced it has rescheduled its 4th annual Investor and Analyst Meeting. The Company will host an Investor and Analyst update as part of its third quarter financial results conference call and webcast on Wednesday, November 9, 2016. "We continue to analyze data from our Resolve clinical trial and ...

Mappel doesn't want to supply US after warning letter

Mappel Indústria de Embalagens says it did not know the US would regulate the dermacosmetic products made at its Sao Paulo plant as OTC drugs after FDA warning.

Terri L. Hemerson, RN Recognized as a Professional of the Year by Strathmore's Who's Who Worldwide Publication

Cedar Rapids, IA, October 08, 2016 --( Terri L. Hemerson, RN of Cedar Rapids, Iowa has been recognized as a Professional of the Year for 2016 by Strathmore’s Who’s Who Worldwide Edition for her outstanding contributions and achievements for over 40 years in the field of healthcare. About Terri L. Hemerson, RN Ms. Hemerson is a Registered Nurse, traveling and staffing hospita...

Pembrolizumab new option for firstline treatment of advanced lung cancer with high PDL-1 expression

Dr Reck meets with ecancertv at ESMO 2016 to discuss results from the KEYNOTE-024 trial which he believes recommend the use of PD1 antibody pembrolizumab as first-line therapy for patients with NSCLC whose tumours express high levels of PDL-1. Video of...

Sercon IRMS-Liquid Chromatography Interface

For the analysis of compounds that are not amenable to gas chromatography, or to avoid derivatisation that may complicate the isotopic analysis, high-pressure liquid chromatography linked directly to isotope ratio monitoring mass spectrometers may provide the solution. With the launch of its LC-I-20-22 system, Sercon has developed a novel and robust method of interfacing HPLC and the 20-22 IRMS t...

Viola Davis teams up with Vaseline Healing Project on community health fair

Gina AcostaThe Vaseline Healing Project is working to close the skin health treatment gap for Americans by providing dermatological care and training to those with limited access to quality care. read more

Must Watch Stocks for October 10, 2016

Shares of Best Buy Co Inc gained Friday, on unconfirmed market chatter of interest from private equity. "Sources" say there is talk of a deal around $50 per share.

From Zika to gun violence, CME sessions at 2016 Interim Meeting

Numerous continuing medical education (CME) courses will be available for credit at the 2016 AMA Interim Meeting in Orlando this November. Among the hot topics: gun violence, the Zika virus and physician burnout. This year’s meeting features expert speakers from public health organizations, physician practices and government agencies. Education sessions and forums sponsored by AMA sections a...

Elderly and disabled people put ‘at risk’ by care homes closures – The Guardian

The GuardianElderly and disabled people put 'at risk' by care homes closuresThe GuardianThe number of care homes in England has fallen from 18,068 in 2010 to 16,614 last July. Photograph: Denis Closon/Rex Features. Denis Campbell Health policy editor. Tuesday 11 October 2016 16.20 EDT Last modified on Tuesday 11 October 2016 16.31 ...Care sector woes leave frail at risk, regulator saysBBC NewsSils...

Quick Search